Antitumour polycyclic acridines. Part 2. Physicochemical studies on the interactions between DNA and novel polycyclic acridine derivatives

Anti-Cancer Drug Design

Volumn 13, Issue 2, 1998, Pages 125-143

  Giménez Arnau, Elena ^a   Missailidis, Sotiris ^a   Stevens, Malcolm F G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Circular dichroism; DNA binding; Fluorescence quenching; Linear dichroism; Polycyclic acridine derivatives; Spectrophotometric analysis; Thermal denaturation; Topoisomerase II

Indexed keywords

ACRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; DNA; POLY(DEOXYADENYLATE DEOXYTHYMIDYLATE); PROFLAVINE;

ARTICLE; BINDING AFFINITY; CHROMATOPHORE; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA DENATURATION; DRUG DNA INTERACTION; LINEAR DICHROISM; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ACRIDINES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CHEMISTRY, PHYSICAL; CIRCULAR DICHROISM; DNA; DRUG STABILITY; HEAT; HYDROGEN-ION CONCENTRATION; KINETICS; MALE; POLYCYCLIC HYDROCARBONS, AROMATIC; SALMON; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0031930370     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. ACHESON, R.M. (1973). The interaction of acridines with nucleic acids. In Acridines, 2nd edn. p. 723. John Wiley & Sons Publishing Co.: New York.
2. ALBERT, A. (1966). In The Acridines, 2nd edn. Edward Arnold: London.
3. ALBERT, A. (1973). In The Acridines: Their Preparation, Physical, Chemical And Biological Properties And Uses, 2nd edn. p. 159. Edward Arnold: London.
4. ALBERT, A (1985). In Selective Toxicity, 7th edn. p. 379. Chapman & Hall: London.
5. ARMSTRONG, R.W., KURUCSEV, T. & STRAUSS, U.P. (1970). The interaction between acridine dyes and deoxyribonucleic acid. Journal of the American Chemical Society, 92, 3174.
6. BAGULEY, B C. (1991). DNA intercalating anti-tumour agents. Anti-Cancer Drug Design, 6, 1.
7. BAILLY, C., POMMERY, N., HOUSSIN, R. & HÉNICHART, J.-P. (1989). Design, synthesis, DNA binding, and biological activity of a series of DNA minor-groove binding intercalating drugs. Journal of Pharma- ceutical Sciences, 78, 910.
8. BAILLY, F., BAILLY, C., HELBECQUE, N., POMMERY, N., COLSON, P., HOUSSIER, C. & HÉNICHART, J.-P. (1992). Relationship between DNA-binding and biological activity of anilinoacridine derivatives containing the nucleic acid-binding unit SPKK. Anti-Cancer Drug Design, 7, 83.
9. BECKER, H.C. & NORDEN, B. (1996). DNA binding properties of 2,7-diazapyrene and its N-methylated cations studied by linear and circular dichroism spectroscopy and calorimetry. Journal of the American Chemistry Society, 119, 5798.
10. BOYD, M.R. & PAULL, K.D. (1995). Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Development Research, 34, 91.
11. DENNY, W.A., ATWELL, G. J. & BAGULEY, B.C. (1983). Potential antitumor agents. 39. Anilino ring geometry of amsacrine and derivatives: relationship to DNA binding and antitumor activity. Journal of Medicinal Chemistry, 26, 1625.
12. DENNY, W.A. (1992). In The Search for New Anticancer Drugs. Waring, M.J. & Ponder, B.A.J. (eds), p. 19. Kluwer Academic Publishers: Dordrecht.
13. DENNY, W.A. & BAGULEY, B C. (1994). New anticancer acridines. In Molecular Aspects of Anticancer Drug-DNA Interaction. Neidle, S. & Waring, M.J. (eds), p. 270. Macmillan Publishing Co.: London.
14. DOUGHERTY, G. & PIGRAM, W.J. (1982). Spectroscopic analysis of drug nucleic acid interactions. CRC Critical Reviews in Biochemistry, 12, 103.
15. DRAKE, F.H., HOFMANN, G.A., BARTUS, H.F., MATTERN, M.R., CROOKE, S.T. & MIRABELLI, C.K. (1989). Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry, 28, 8154.
16. FINLAY, G.J., RIOU, J.-F. & BAGULEY B.C. (1996). From amsacrine to DACA (N-[2-dimethylamino)-ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivatives. European Journal of Cancer, 32A, 708.
17. HAGAN, D.J., GIMENEZ-ARNAU, E., SCHWALBE, C.H & STEVENS, M.F.G. (1997). Antitumour polycyclic acridines. Part 1. Synthesis of 7H-pyrido- and 8H-quino [4,3,2-kl]-acridines by Graebe-Ullmann thermolysis of 9-(1,2,3-triazol-1-yl)acridines: application of differential scanning calorimetry to predict optimum cyclisation conditions. Journal of the Chemical Society, Perkin Transactions 1, 18, 2739.
18. HARRIS, C.J. (1996). Structure and function of p53 tumor supressor gene: clues for rational cancer therapeutic strategies. Journal of the National Cancer Institute, 88, 1442.
19. HOULBROOK, S., ADDISON, C.M., DAVIES, S.L., CARMICHAEL, J., STRATFORD, I.J., HARRIS, A.L. & HICKSON, I.D. (1995). Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines. British Journal of Cancer, 72, 1454.
20. HUDDART, R.A., TITLEY, J., ROBERTSON, D, WILLIAMS, G.T., HORWICH, A. & COOPER, C S. (1995). Programmed cell death in response to chemotherapeutic agents in human germ cell tumour lines. European Journal of Cancer, 31A, 739.
21. JONES, G.B., DAVEY, C.L., JENKINS, T.C., KAMAL, A., KNEALE, G., NEIDLE, S., WEBSTER G.D. & THURSTON, D.E. (1990). The non-covalent interaction of pyrrolo [2,1-c][1,4] benzodiazepine-5,11-diones with DNA. Anti-Cancer Drug Design, 5, 249.
22. 2 studied by CD, LD, and normal absorption. Biochemistry, 35, 1187.
23. KOHN, K.W. (1996). Beyond DNA cross-linking: history and prospects of DNA-targeted cancer treatment. Cancer Research, 56, 5533.
24. LYNG, R , RODGER, A. & NORDEN, B. (1991). The CD of ligand-DNA systems. 1. Poly(dG-dC) B-DNA. Biopolymer, 31, 1709.
25. LYNG, R., RODGER, A. & NORDEN, B. (1992). The CD of ligand-DNA systems. 2. Poly(dA-dT) B-DNA. Biopolymer, 32, 1201.
26. MCCONNAUGHIE, A.W. & JENKINS, T.C. (1995). Novel acridine-triazenes as prototype combilexins: synthesis, DNA binding, and biological activity. Journal of Medicinal Chemistry, 38, 3488.
27. MCGHEE, J.D. & VON HIPPEL, P.H. (1974). Theoretical aspects of DNA protein interactions: cooperative and non-cooperative binding of large ligands to a one dimensional homogeneous lattice. Journal of Molecular Biology, 86, 469.
28. MORGAN, A.R., LEE, J.S., PULLEYBLANK, D.E., MURRAY, N.L. & EVANS, D.H. (1979). Ethidium fluorescence assays. Part 1. Physicochemical studies. Nucleic Acids Research, 7, 547.
29. NORDEN, B. & TJERNELD, F. (1982). Structure of methylene-blue-DNA complexes studied by linear and circular dichroism spectroscopy. Biopolymers, 21, 1713.
30. NORDEN, B., KUBISTA, M. & KURUCSEV, T (1992). The linear dichroism spectroscopy of nucleic acids. Quarterly Reviews of Biophysics, 25, 51.
31. PEACOCKE, A.R. (1973). The interaction of acridines with nucleic acids. In Acridines, 2nd edn. Acheson, R.M. (ed.), p. 723. John Wiley & Sons: New York.
32. PEACOCKE, A.R. & SKERRETT, J.N.H (1956). The interaction of aminoacridines with nucleic acids. Transactions of the Faraday Society, 52, 261.
33. PILCH, D.S., MARTIN, M.-T., NGUYEN, C.H., SUN, J.S., BISAGNI, E., GARESTIER, T. & HELENE, C. (1993). Self-association and DNA-binding properties of two triple helix-specific ligands: comparison of a benzo[e]pyrido- indole and a benzo[g]pyridoindole. Journal of the American Chemical Society, 115, 9942.
34. PRATT, W.B., RUDDON, R.W., ENSMINGER, W.D. & MAYBAUM, J. (1994). Inhibitors of chromatin function. In The Anticancer Drugs, p. 183. Oxford University Press: New York.
35. SANDRI, M.I., HOCHHAUSER, D , AYTON, P., CAMPLEJOHN, R.C., WHITEHOUSE, R., TURLEY, H., GATTER, K., HICKSON, I.D. & HARRIS, A.L. (1996). Differential expression of the topoisomerase II-α and β-genes in human breast cancers. British Journal of Cancer, 73, 1518.
36. SCATCHARD, J. (1949). The attractions of proteins for small molecules and ions. Annals of the New York Academy of Sciences, 51, 660.
37. SELISKAR, C.J. & BRAND, L. (1971). Electronic spectra of 2-aminonaphthalene-6-sulfonate and related molecules. II. Effects of solvent medium on the absorption and fluorescence spectra. Journal of the American Chemical Society, 93, 5414.
38. VOSBERG, PH. (1985). DNA topoisomerase: enzymes that control DNA conformation. Current Topics in Microbiology and Immunology, 114, 19.
39. WADA, A. (1964). Chain regularity and flow dichroism of deoxyribonucleic acids in solution. Biopolymers, 2, 361.
40. WADA, A & KOZAWA, S. (1964). Instrument for studies of differential flow dichroism of polymer solutions. Journal of Polymer Science, Part A, 2, 853.
41. WANG, J.C. (1985). DNA topoisomerases. Annual Review of Biochemistry, 54, 665.
42. WEINSTEIN, J.N., MYERS, T.G, O'CONNOR, P.M., FRIEND, S.H., FORNACE, A.J., KOHN, K.W., FOJO, T., BATES, S.E., RUBINSTEIN, L.V , ANDERSON, N L., BUOLAMWINI, J.K , VAN OSDOL, W.W., MONKS, A.P., SCUDIERO, D.A., SANSVILLE, E.A., ZAHAREVITZ, D.W., BUNOW, B., VISWANADHAN, V.N , JOHNSON, G.S., WITTES, R.E. & PAULL, K.D. (1997). An information intensive approach to the molecular pharmacology of cancer. Science, 275, 343.
43. WILSON, W.R., BAGULEY, B.C., WAKELIN, L.P.G & WARING, M J. (1981). Interaction of the antitumour drug m-AMSA (4′-(9-acridinylamino)methanesulphon-m-anisidide) and related acridines with nucleic acids. Molecular Pharmacology, 20, 404.